发明名称 HIV-encoded chemoattractant
摘要 The combination of HIV proteins Tat and Nef is chemotactic for CD4+ cells. Utilizing the capacity of Tat and Nef to modulate CD4+ cell trafficking and infiltration, the invention provides various treatment modes for individuals infected with HIV. The invention further provides treatment modes for other localized diseases by controlling CD4+ cell trafficking and infiltration. In particular, the invention provides methodology for promoting CD4+ cell chemotaxis to a localized site of infection as a means of augmenting the efficacy of extant chemotherapeutic methods. The invention further provides methodology for diverting CD4+ cell infiltration from a localized site where the presence of CD4+ cells is detrimental to the clinical outcome, by providing a composition comprising Tat and Nef at a distinct site, such as blood, within the individual where the accumulation of CD4+ cells is less detrimental.
申请公布号 US6878685(B2) 申请公布日期 2005.04.12
申请号 US20020274361 申请日期 2002.10.21
申请人 UNIVERSITY OF IOWA RESEARCH FOUNDATION 发明人 SOLL DAVID R.;SHUTT DAMON
分类号 A61K38/16;A61K38/20;A61K39/39;A61P31/18;C07K14/16;(IPC1-7):A61K38/01;A61K38/19;A61K51/00;A61K51/08;A61K45/08;A61K39/21 主分类号 A61K38/16
代理机构 代理人
主权项
地址